Gretchen Schweitzer (Trophic Communications GmbH)

Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office)

	Organisation	Trophic Communications GmbH
	Former/major organisation	MacDougall Biomedical Communications Inc. (MBI), European Office
	Group	MacDougall Biomedical Communications Inc. (MBI)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2024-07-17

Picture Berlin Partner Voices Uirá Souto Melo Lucid Genomics 650x200px

More documents for Gretchen Schweitzer

[1] Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich....
[2] Osivax SAS. (7/8/20). "Press Release: Osivax Receives Over EUR 30m in Public Funding to Support Development of Universal Coronavirus & Influenza Vaccines". Lyon....
[3] BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz....
[4] BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz....
[5] Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale)....
[6] BioNTech SE. (5/8/19). "Press Release: BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio". Mainz....
[7] Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]